Remove 2017 Remove DEA Remove Policy
article thumbnail

The Tom Marino Roller Coaster: Three Days of Drug Policy Changes

Americans for Safe Access

On October 15, 2017, the Washington Post and 60 Minutes released a scathing report on the pharmaceutical industry’s influence of the Drug Enforcement Administration (DEA).

Policy 182
article thumbnail

5 Medical Cannabis Strains That Can be Used to Treat PTSD

FloridaMarijuana.net

MAPS worked for over 22 years to obtain marijuana for medical marijuana drug development research, and the approval is a historic shift in federal policy. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs). 5 cannabis strains to treat PTSD: 1.

Strains 190
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Charles Feldmann to Speak at Canna Tech Global

MJ Business Attorneys

CannaTech showcases the biggest industry thought leaders, known for their significant and groundbreaking contributions to the global cannabis market in fields such as science, finance, government policy and tech. policy towards marijuana. January 2017 — Inauguration Day. Where is it all headed?”

DEA 100
article thumbnail

DEA finally ends fed monopoly on schwaggy research-grade cannabis

SpeedWeed

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. Leafly’s Ben Adlin documented the shockingly poor quality in this 2017 article : Smoking 25% THC, studying 8% THC. DEA finally relents.

DEA 52
article thumbnail

The Ketamine Clinic Craze: Legalities and Possibilities

Canna Law Blog

Whomever on site is administering, manufacturing, storing, or distributing the drug, from the doctor to the nurse practitioner to the on-site pharmacist, must register with the DEA in accordance with Part 1301 of Title 21 of the Code of Federal Regulations on and after August 12, 1999.

Therapy 102
article thumbnail

Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative @ Harvard

Cannabis Law Report

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. POPLAR will publish original law and policy research. CR: Can you describe the existing landscape of psychedelics research?

Law 81
article thumbnail

American Action Forum: Federal Taxation Of Cannabis : Primer

Cannabis Law Report

3] Further, notwithstanding the determination of the Drug Enforcement Administration (DEA), which is required to defer to the Department of Health and Human Services’ assessment that cannabis has no acceptable medical utility, 37 states and four territories have enacted laws allowing for the medical use of cannabis products. [4]

Policy 100